AXL is a predictor of poor survival and of resistance to anti-EGFR therapy in RAS wild-type metastatic colorectal cancer

Claudia Cardone, Bernadette Blauensteiner, Verónica Moreno‐Viedma, Giulia Martini, Vittorio Simeon, Pietro Paolo Vitiello, Davide Ciardiello, Valentina Belli, Nunzia Matrone, Teresa Troiani, Floriana Morgillo, Federica Zito Marino, Monica Dentice, Annarita Nappi, Alessandra Boccaccino, Carlotta Antoniotti, Chiara Cremolini, Filippo Pietrantonio, Gerald W. Prager, Nicola Normanno, Evaristo Maiello, Guillem Argilés, Élena Elez, Giuseppe Signoriello, Renato Franco, Alfredo Falcone, Josep Tabernero, Maria Sibilia, Fortunato Ciardiello, Erika Martinelli